Magno Cheryl P, Araneta Maria Rosario G, Macera Caroline A, Anderson Gwen W
Graduate School of Public Health, San Diego State University, San Diego, California, USA.
Ethn Dis. 2008 Autumn;18(4):458-63.
This cross-sectional study was designed to examine the association between adiponectin and cardiovascular disease (CVD) among an understudied ethnic group of Filipino American women.
We recruited 266 Filipino women aged 40-86 years from the University of California, San Diego Filipino Women's Health Study (1995-1999). Plasma adiponectin was extracted from archive blood samples and measured by radioimmunoassay. CVD was defined as coronary heart disease, angina, myocardial infarction, or stroke by history, electrocardiogram (Minnesota coding), or Rose questionnaire.
CVD prevalence among Filipinas was 20.7% (n=55), of which 85.5% were newly diagnosed. Filipinas with versus without CVD had more antihypertensive medication use (44.4% vs 26.7%), more parental history of myocardial infarction (38.2% vs 21.8%), higher proinsulin levels (13.2 vs 11.0 pmol/L), lower adiponectin levels (5.09 vs 6.15 microg/mL), and higher prevalences of the metabolic syndrome (34.6% vs 28.0%) and microalbuminuria (24.0% vs 12.2%). Adiponectin (adjusted OR .46, 95% CI .23-.89, P=.021) was independently associated with CVD in multivariate analysis that adjusted for age, exercise, family history, diabetes, hypertension, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and microalbuminuria.
Independent of known risk factors, adiponectin was associated with CVD among Filipinas. This finding suggests that adiponectin may be a useful CVD indicator among this ethnic population.
本横断面研究旨在调查在研究较少的菲律宾裔美国女性族群中脂联素与心血管疾病(CVD)之间的关联。
我们从加利福尼亚大学圣地亚哥分校菲律宾女性健康研究(1995 - 1999年)中招募了266名年龄在40 - 86岁的菲律宾女性。从存档血液样本中提取血浆脂联素,并通过放射免疫测定法进行测量。CVD通过病史、心电图(明尼苏达编码)或罗斯问卷定义为冠心病、心绞痛、心肌梗死或中风。
菲律宾女性中CVD患病率为20.7%(n = 55),其中85.5%为新诊断病例。患有与未患有CVD的菲律宾女性使用抗高血压药物的比例更高(44.4%对26.7%),有心肌梗死家族史的比例更高(38.2%对21.8%),胰岛素原水平更高(13.2对11.0 pmol/L),脂联素水平更低(5.09对6.15 μg/mL),代谢综合征(34.6%对28.0%)和微量白蛋白尿(24.0%对12.2%)的患病率更高。在对年龄、运动、家族史、糖尿病、高血压、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇和微量白蛋白尿进行调整的多变量分析中,脂联素(调整后的OR为0.46,95%CI为0.23 - 0.89,P = 0.021)与CVD独立相关。
独立于已知风险因素,脂联素与菲律宾女性中的CVD相关。这一发现表明脂联素可能是该族群人群中有用的CVD指标。